Filtros : "Pogribny, Igor P" Removido: "Furtado, kelly Silva" Limpar

Filtros



Refine with date range


  • Source: Journal of Nutritional Biochemistry. Unidade: FCF

    Subjects: LIPÍDEOS, CARCINOGÊNESE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CONTI, Aline de et al. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis. Journal of Nutritional Biochemistry, v. 86, p. 1-9 art. 108496, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jnutbio.2020.108496. Acesso em: 02 nov. 2025.
    • APA

      Conti, A. de, Tryndyak, V., Heidor, R., Jimenez, L., Moreno, F. S., Beland, F. A., et al. (2020). Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis. Journal of Nutritional Biochemistry, 86, 1-9 art. 108496. doi:10.1016/j.jnutbio.2020.108496
    • NLM

      Conti A de, Tryndyak V, Heidor R, Jimenez L, Moreno FS, Beland FA, Rusyn I, Pogribny IP. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis [Internet]. Journal of Nutritional Biochemistry. 2020 ; 86 1-9 art. 108496.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.jnutbio.2020.108496
    • Vancouver

      Conti A de, Tryndyak V, Heidor R, Jimenez L, Moreno FS, Beland FA, Rusyn I, Pogribny IP. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis [Internet]. Journal of Nutritional Biochemistry. 2020 ; 86 1-9 art. 108496.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.jnutbio.2020.108496
  • Source: Cancer Research. Conference titles: American Association for Cancer Research/AACR Annual Meeting. Unidade: FCF

    Subjects: CARCINOMA HEPATOCELULAR, CARCINOGÊNESE

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ORTEGA, Juliana Festa et al. Role of miRNAome deregulation in the pathogenesis of non-alcoholic steatohepatitis (NASH)-derived hepatocellular carcinoma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 nov. 2025. , 2017
    • APA

      Ortega, J. F., De Conti, A., Dreval, K., Moreno, F. S., Beland, F. A., & Pogribny, I. P. (2017). Role of miRNAome deregulation in the pathogenesis of non-alcoholic steatohepatitis (NASH)-derived hepatocellular carcinoma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
    • NLM

      Ortega JF, De Conti A, Dreval K, Moreno FS, Beland FA, Pogribny IP. Role of miRNAome deregulation in the pathogenesis of non-alcoholic steatohepatitis (NASH)-derived hepatocellular carcinoma. Cancer Research. 2017 ; 77( 13):[citado 2025 nov. 02 ]
    • Vancouver

      Ortega JF, De Conti A, Dreval K, Moreno FS, Beland FA, Pogribny IP. Role of miRNAome deregulation in the pathogenesis of non-alcoholic steatohepatitis (NASH)-derived hepatocellular carcinoma. Cancer Research. 2017 ; 77( 13):[citado 2025 nov. 02 ]
  • Source: Oncotarget. Unidade: FCF

    Subjects: CARCINOGÊNESE, CARCINOMA HEPATOCELULAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CONTI, Aline de et al. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis. Oncotarget, v. 8, n. 51, p. 88517-88528, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.19774. Acesso em: 02 nov. 2025.
    • APA

      Conti, A. de, Ortega, J. F., Tryndyak, V., Dreval, K., Moreno, F. S., Rusyn, I., et al. (2017). MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis. Oncotarget, 8( 51), 88517-88528. doi:10.18632/oncotarget.19774
    • NLM

      Conti A de, Ortega JF, Tryndyak V, Dreval K, Moreno FS, Rusyn I, Beland FA, Pogribny IP. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis [Internet]. Oncotarget. 2017 ; 8( 51): 88517-88528.[citado 2025 nov. 02 ] Available from: https://doi.org/10.18632/oncotarget.19774
    • Vancouver

      Conti A de, Ortega JF, Tryndyak V, Dreval K, Moreno FS, Rusyn I, Beland FA, Pogribny IP. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis [Internet]. Oncotarget. 2017 ; 8( 51): 88517-88528.[citado 2025 nov. 02 ] Available from: https://doi.org/10.18632/oncotarget.19774
  • Source: Nutrition and Cancer. Unidade: FCF

    Subjects: CARCINOMA HEPATOCELULAR, NUTRIÇÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MORENO, Fernando Salvador e HEIDOR, Renato e POGRIBNY, Igor P. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutrition and Cancer, v. 68, n. 5, p. 719-733, 2016Tradução . . Disponível em: https://doi.org/10.1080/01635581.2016.1180410. Acesso em: 02 nov. 2025.
    • APA

      Moreno, F. S., Heidor, R., & Pogribny, I. P. (2016). Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutrition and Cancer, 68( 5), 719-733. doi:10.1080/01635581.2016.1180410
    • NLM

      Moreno FS, Heidor R, Pogribny IP. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents [Internet]. Nutrition and Cancer. 2016 ; 68( 5): 719-733.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1080/01635581.2016.1180410
    • Vancouver

      Moreno FS, Heidor R, Pogribny IP. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents [Internet]. Nutrition and Cancer. 2016 ; 68( 5): 719-733.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1080/01635581.2016.1180410
  • Source: Carcinogenesis. Unidade: FCF

    Subjects: CARCINOGÊNESE ANIMAL, NEOPLASIAS (QUIMIOTERAPIA)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DE CONTI, Aline et al. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis, v. 34, n. 8, p. 1900-1906, 2013Tradução . . Disponível em: https://doi.org/10.1093/carcin/bgt124. Acesso em: 02 nov. 2025.
    • APA

      De Conti, A., Tryndyak, V., Koturbash, I., Heidor, R., Kuroiwa-Trzmielina, J., Ong, T. P., et al. (2013). The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis, 34( 8), 1900-1906. doi:10.1093/carcin/bgt124
    • NLM

      De Conti A, Tryndyak V, Koturbash I, Heidor R, Kuroiwa-Trzmielina J, Ong TP, Beland FA, Moreno FS, Pogribny IP. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway [Internet]. Carcinogenesis. 2013 ; 34( 8): 1900-1906.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1093/carcin/bgt124
    • Vancouver

      De Conti A, Tryndyak V, Koturbash I, Heidor R, Kuroiwa-Trzmielina J, Ong TP, Beland FA, Moreno FS, Pogribny IP. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway [Internet]. Carcinogenesis. 2013 ; 34( 8): 1900-1906.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1093/carcin/bgt124

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025